Clinical trial
Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem…
NCT00410631 · German Society for Pediatric Oncology and Hematology GPOH gGmbH, Other · Unknown status
Key facts
| NCT number | NCT00410631 |
|---|---|
| Title | Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma |
| Official title | NB2004 Trial Protocol for Risk Adapted Treatment of Children With Neuroblastoma |
| Lead sponsor | German Society for Pediatric Oncology and Hematology GPOH gGmbH, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, carboplatin, cisplatin, cyclophosphamide, dacarbazine, doxorubicin hydrochloride, etoposide phosphate, ifosfamide, isotretinoin, melphalan and 8 more |
| Enrollment | 642 |
| Start date | Oct 1, 2004 |
| Primary completion | Dec 1, 2010 |
| First posted | Dec 13, 2006 |
| Last update posted | Aug 7, 2013 |
| Countries | Germany, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: